A high prevalence of hepatitis C virus (HCV) infection in patients with B-cell non-Hodgkin's lymphoma (B-NHL) has been reported in some, but not all, studies, and the association showed a strong regional variation. We conducted a systematic review of the prevalence of HCV infection in case series of B-NHL and, when an appropriate control group was available, of the odds ratio of B-NHL associated with HCV infection. A high HCV prevalence in B-NHL was found in southern and eastern Europe, Japan and the southern United States, but not in central and northern Europe, Canada, northern United States, or a few Asian countries. Possible sources of heterogeneity and bias are discussed. The odds ratio of B-NHL for HCV infection was relatively weak, ranging from 2 to 4 in most studies. Thus, even if the observed association were causal, the percentage of cases of B-NHL attributable to HCV infection would be relatively low (10%) also in countries with a high prevalence of HCV infection in the general population, and extremely low in other countries. This may explain apparent inconsistencies between studies. Potential mechanisms of action are also discussed. © 2004 Wiley-Liss, Inc.
Key words: hepatitis C virus; non-Hodgkin's lymphoma; Hodgkin's lymphoma; multiple myeloma; chronic lymphocytic leukemiaHepatitis C virus (HCV) is an RNA virus that belongs to the family of flaviviruses. It is hepatotrophic and causes hepatitis, liver cirrhosis and hepatocellular carcinoma. 1 HCV infection is sometimes accompanied by autoimmune manifestations, most notably essential mixed cryoglobulinemia (EMC), which is characterized by cutaneous vasculitis, nephritis, peripheral neuropathy and clonal B-cell lymphoproliferations. 2 HCV infection has also been involved in a subset of non-Hodgkin's lymphomas (NHLs), even in the absence of EMC. Higher than expected HCV prevalence among NHL patients has emerged, however, chiefly from studies in Italy 3,4 and Japan, 5,6 where intermediate to high prevalence of HCV (2-10%) can be found in the general population.Elucidating the causes of NHL is of great importance, since the disease is one of the few neoplasms showing unexplained upward trends in incidence and mortality rates in the last decades. 7,8 We therefore conducted a systematic review of published studies on HCV infection and NHL.
MATERIAL AND METHODSWe identified peer-reviewed articles on HCV and NHL through a MEDLINE and EMBASE search, personal knowledge of the authors and the references of the retrieved articles. Key search words included the terms "hepatitis" and "lymphoma." No language or age limitation was imposed. We included articles published up to June 2003. Our primary aim was to identify all articles that presented the prevalence of HCV infection in case series of B-cell NHL patients and, if possible, in some appropriate control group. To avoid multiple inclusions of the same data, whenever the same author appeared in more than one article, we checked the place and time of recruitment of cases and, in case of overlapping, included th...